Clinical Nurse Specialist in Tell City, IN Accepting Medicare

6 Clinical Nurse Specialist nurses found. Showing 1 - 6

Vanessa Lynn Barger, LPN Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-629-6104

Amanda Rae Ramsey, Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-547-2333    Fax: 812-547-2312

Amelia Hess, LPN Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-547-2333

Emily Farris, RN Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-547-2333

Gwynda Sue Litherland, LPN Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-547-2333

Terissa Roark, Clinical Nurse Specialist - Long-Term Care Medicare: Not Enrolled in Medicare Practice Location: 1143 23rd St, Tell City, IN 47586 Phone: 812-547-2333

News Archive

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.

Unique genetic signature alerts physicians to high-risk breast tumors

A unique genetic signature can alert physicians to high-risk breast tumors that are masquerading as low-risk tumors, according to research at Washington University School of Medicine in St. Louis and collaborating institutions. Although these tumors are apparently estrogen-receptor positive - meaning they should depend on estrogen to grow - they don't respond well to anti-estrogen therapy.

Quantum Genomics initiates Phase IIa trial for heart failure

Quantum Genomics, a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the initiation of its Phase IIa multicentric clinical trial of GQC101, entitled QUID HF (QUantum Genomics Incremental Dosing in Heart Failure), for the treatment of patients with chronic heart failure. The first three clinical centres of the European trial have been opened in France and Norway.

Restricting salt intake helps control blood pressure in dialysis patients: Research

For kidney patients trying to control their blood pressure, reducing fluid build-up in the blood is more effective than using antihypertensive medications, according to an analysis appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

Less-virulent strain of avian influenza virus can spread from poultry to humans

In findings with implications for pandemic influenza, a new study reports for the first time that a less-virulent strain of avian influenza virus can spread from poultry to humans. The research appears in the October 1 issue of The Journal of Infectious Diseases, now available online.

Read more Medical News

› Verified 3 days ago